2018
DOI: 10.1016/j.jcyt.2018.02.299
|View full text |Cite
|
Sign up to set email alerts
|

Optimizing the culture process of engineered t cells to favor long-term efficacy following adoptive immunotherapy

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles